ODDB.org: Open Drug Database

GlaxoSmithKline AG - Engerix-B 20, Injektionssuspension

Swissmedic Registration	00534	Sequence	01
Product name	Engerix-B 20	Description	Injektionssuspension
ATC-Classification	J07BC01	ATC-Description	Hepatitis B, Purified Antigen
Introduction of Sequence	03.12.1986

Composition

hepatitidis B viri antigenum ADNr 20 µg, aluminium 0.5 mg ut aluminii hydroxidum, natrii chloridum, dinatrii phosphas dihydricus, natrii dihydrogenophosphas dihydricus, aqua ad iniectabile q.s. ad suspensionem pro 1 ml corresp. natrium 3.52 mg.

Packungsbestandteile

Galenic Form

Injection suspension

Excipiens

Active Agent	Dose
Hepatitidis b viri Antigenum Adnr	20 µg/ml

BAG: Active Agent	Dose
Vaccinum Hepatitidis b (Adnr) Hbsag	20 mcg

Inactive agents	Dose
Alumine	0.5 mg/ml
Disodium Phosphate Dihydrate
Sodium Chloride
Sodium Dihydrogenophosphate Dihydrate

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
003		23.66	42.15	B	SL	No
004	10	PR	PR	B		No

2025	©ywesee GmbH